<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03838978</url>
  </required_header>
  <id_info>
    <org_study_id>CP0002 (formerly CLIN102918)</org_study_id>
    <nct_id>NCT03838978</nct_id>
  </id_info>
  <brief_title>Calypso Knee System Clinical Study, OUS</brief_title>
  <official_title>Evaluation of the Calypso Knee System for Symptom Relief in Subjects With Medial Knee Osteoarthritis, OUS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Moximed</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Moximed</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study to evaluate the safety and effectiveness of the Calypso Knee System when used in
      subjects with symptomatic osteoarthritis of the medial compartment of the knee.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, multicenter clinical study of the Calypso Knee System. A total of 80 subjects
      will be enrolled in this study at up to 14 investigational sites located in Europe and in the
      United States (U.S.). A minimum of 35 subjects will be enrolled at up to 7 investigational
      sites in Europe. Male or female subjects age 25 to 65 years, with a diagnosis of medial knee
      osteoarthritis and study knee pain with an overall WOMAC pain score ≥ 40 (scale 0-100).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 8, 2019</start_date>
  <completion_date type="Anticipated">September 2025</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single Arm Study Design</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Pain</measure>
    <time_frame>Change at 24 months relative to baseline</time_frame>
    <description>The WOMAC Pain score is derived from a sub-section of the Knee injury and Osteoarthritis Outcome Score (KOOS) Knee Survey. The WOMAC Pain scores range from 0-100 with lower scores considered lower pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Function</measure>
    <time_frame>Change at 24 months relative to baseline</time_frame>
    <description>The WOMAC Function score is derived from a sub-section of the Knee injury and Osteoarthritis Outcome Score (KOOS) Knee Survey. The WOMAC Function scores range from 0-100 with lower scores considered to have better function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Treatment-Emergent Adverse Events resulting in Secondary Surgical Interventions</measure>
    <time_frame>From baseline to 24 months</time_frame>
    <description>Incidence of Secondary Surgical Intervention due to implant related Adverse Events</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maintenance of Implant Integrity by Radiographic Review</measure>
    <time_frame>From baseline to 24 months</time_frame>
    <description>Implant integrity will be assessed by radiographic review to verify that the implant is not disassembled</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <arm_group>
    <arm_group_label>Calypso Knee System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Calypso Knee System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Calypso Knee System</intervention_name>
    <description>The Calypso Knee System is an extra-capsular knee implant designed to fill the therapeutic gap between conservative care and more invasive surgical interventions for knee osteoarthritis.</description>
    <arm_group_label>Calypso Knee System</arm_group_label>
    <other_name>Calypso System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Participants age - 25 to 65 years

          2. Body Mass Index (BMI) of &lt; 35, Weight &lt; 300 lbs (136 kg)

          3. Knee osteoarthritis pain on the inner side of knee that has continued after at least 6
             months of non-operative treatment

        Exclusion Criteria:

          1. Symptoms of osteoarthritis in the other knee or in lateral (outer) or patellofemoral
             compartments of the target knee

          2. Knee ligament or meniscal instability

          3. Other bone or joint conditions such as Rheumatoid arthritis, Paget's disease,
             Charcot's disease or general conditions such as allergy or hypersensitivity to certain
             metals, active infection, certain neurological conditions, use of medication such as
             steroids or chemotherapy that could impact study participation or results
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandra Kraenzlin</last_name>
    <role>Study Director</role>
    <affiliation>Moximed</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexandra Kraenzlin</last_name>
    <phone>+41 44 515 62 06</phone>
    <email>akraenzlin@moximed.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vijaya Krishnamoorthy</last_name>
    <phone>+1 510-887-3328</phone>
    <email>vkrishnamoorthy@moximed.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UZ Gent</name>
      <address>
        <city>Gent</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Department of Orthopedics and Traumatology</last_name>
      <phone>+32 9332 22 51</phone>
      <email>bws@uzgent.be</email>
    </contact>
    <investigator>
      <last_name>Jan Victor, MD, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zagiel Med Hospital</name>
      <address>
        <city>Lublin</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Carolina Medical Center</name>
      <address>
        <city>Warszawa</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Urszula Zdanowicz</last_name>
      <phone>+ 48 509 859 525</phone>
      <email>u.zdanowicz@icloud.com</email>
    </contact>
    <investigator>
      <last_name>Urszula Zdanowicz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinika Chirurgii Kolana Dr Słynarskiego</name>
      <address>
        <city>Warszawa</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gabinet Ortopedyczny Marcin Domżalski - SPORTO</name>
      <address>
        <city>Łódź</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcin Domżalski</last_name>
      <phone>+48 502 063 224</phone>
      <email>marcindomzalski@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Marcin Domżalski, MD, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Poland</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>February 11, 2019</study_first_submitted>
  <study_first_submitted_qc>February 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2019</study_first_posted>
  <last_update_submitted>June 8, 2020</last_update_submitted>
  <last_update_submitted_qc>June 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

